Bioengineering bacterial encapsulin nanocompartments as targeted drug delivery system

Autor: Kenth Gustafsson, Rana Khalife, Konstantin Pildish, Rupali Dabas, Sofia Esteban Serna, Vladimir Kalinovskiy, Noelle Colant, Matas Deveikis, Alexander Van de Steen, Saverio Charalambous, Hasan Mustafa Khan, Stefanie Frank, Clare M. Robinson, Diana A. Catana
Jazyk: angličtina
Rok vydání: 2021
Předmět:
QH301-705.5
His6
Hexahistidine

Encapsulin
Drug delivery system
Biomedical Engineering
NPs
NanoParticles

rTurboGFP
recombinant Turbo Green Fluorescent Protein

Applied Microbiology and Biotechnology
Article
law.invention
iLOV
improved Light
Oxygen or Voltage-sensing flavoprotein

mScarlet
a bright monomeric red fluorescent protein

STII
StrepII-tag
an eight-residue peptide sequence (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) with intrinsic affinity toward streptavidin that can be fused to recombinant protein in various fashions

Nanocages
DDS
Drug Delivery System

Structural Biology
In vivo
law
SK-BR-3
Sloan-Kettering Breast cancer cell line/HER2-overexpressing human breast cancer cell line

Genetics
Cytotoxic protein
Annexin V-FITC
Annexin V-Fluorescein IsoThiocyanate Conjugate

T. maritima
Thermotoga maritima

Biology (General)
HER2
Human Epidermal growth factor Receptor 2

DARPin9.29
Designed Ankyrin Repeat Protein 9.29

biology
Chemistry
iGEM
international Genetically Engineered Machine

EPR
Enhanced Permeability and Retention effect

biology.organism_classification
Fusion protein
Cell biology
DARPin
Targeted drug delivery
Thermotoga maritima
Drug delivery
miniSOG
mini-Singlet Oxygen Generator

Recombinant DNA
MSCs
Mesenchymal Stem Cells

VLPs
Virus-Like Particle

TP248.13-248.65
Biotechnology
Zdroj: Synthetic and Systems Biotechnology, Vol 6, Iss 3, Pp 231-241 (2021)
Synthetic and Systems Biotechnology
Popis: The development of Drug Delivery Systems (DDS) has led to increasingly efficient therapies for the treatment and detection of various diseases. DDS use a range of nanoscale delivery platforms produced from polymeric of inorganic materials, such as micelles, and metal and polymeric nanoparticles, but their variant chemical composition make alterations to their size, shape, or structures inherently complex. Genetically encoded protein nanocages are highly promising DDS candidates because of their modular composition, ease of recombinant production in a range of hosts, control over assembly and loading of cargo molecules and biodegradability. One example of naturally occurring nanocompartments are encapsulins, recently discovered bacterial organelles that have been shown to be reprogrammable as nanobioreactors and vaccine candidates. Here we report the design and application of a targeted DDS platform based on the Thermotoga maritima encapsulin reprogrammed to display an antibody mimic protein called Designed Ankyrin repeat protein (DARPin) on the outer surface and to encapsulate a cytotoxic payload. The DARPin9.29 chosen in this study specifically binds to human epidermal growth factor receptor 2 (HER2) on breast cancer cells, as demonstrated in an in vitro cell culture model. The encapsulin-based DDS is assembled in one step in vivo by co-expressing the encapsulin-DARPin9.29 fusion protein with an engineered flavin-binding protein mini-singlet oxygen generator (MiniSOG), from a single plasmid in Escherichia coli. Purified encapsulin-DARPin_miniSOG nanocompartments bind specifically to HER2 positive breast cancer cells and trigger apoptosis, indicating that the system is functional and specific. The DDS is modular and has the potential to form the basis of a multi-receptor targeted system by utilising the DARPin screening libraries, allowing use of new DARPins of known specificities, and through the proven flexibility of the encapsulin cargo loading mechanism, allowing selection of cargo proteins of choice.
Databáze: OpenAIRE